Drug induced liver injury liver biopsy: Difference between revisions
No edit summary |
mNo edit summary |
||
| (2 intermediate revisions by one other user not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no specific liver biopsy findings diagnostic of drug induced injury, but there are several broad histological patterns that reflect the type of injury caused by the inciting drug. | There are no specific liver biopsy findings diagnostic of drug induced injury, but there are several broad histological patterns that reflect the type of injury caused by the inciting drug. Moreover, the same medication can induce a different pattern of liver injury depending on the patient. | ||
==Liver Biopsy== | ==Liver Biopsy== | ||
The most common histological patterns seen in the drug induced liver injury network are as follows: | The most common histological patterns seen in the drug induced liver injury network are as follows: | ||
*Acute hepatitis (21%) | *[[Acute hepatitis]] (21%) | ||
*Chronic hepatitis (14%) | *[[Chronic hepatitis]] (14%) | ||
*Cholestatic hepatitis (29%) | *[[Cholestatic]] hepatitis (29%) | ||
*Acute cholestasis (9%) | *Acute [[cholestasis]] (9%) | ||
*Chronic cholestasis (10%) | *Chronic [[cholestasis]] (10%) | ||
On biopsy, drug induced liver injury is characterized by hepatocellular injury and severe [[inflammation]], [[necrosis]], [[hemorrhage]], and rosette formation. Patients with [[cholestatic]] injury tend to have [[Paucity of interlobular bile ducts|more bile plugs and duct paucity]]. Certain findings on biopsy are predictive of severe and even fatal hepatic injury, including higher degrees of [[necrosis]], microvesicular [[steatosis]], [[fibrosis], and duct reactions. In contrast, [[eosinophil]]s and [[granuloma]]s are associated with milder injury.<ref name="pmid24037963">{{cite journal| author=Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB et al.| title=Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. | journal=Hepatology | year= 2014 | volume= 59 | issue= 2 | pages= 661-70 | pmid=24037963 | doi=10.1002/hep.26709 | pmc=3946736 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24037963 }} </ref> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 19:28, 26 October 2016
|
Drug induced liver injury Microchapters |
|
Differentiating Drug Induced Liver Injury from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Drug Induced Liver Injury On the Web |
|
American Roentgen Ray Society Images of Drug induced liver injury |
|
Risk calculators and risk factors for Drug induced liver injury |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Rachita Navara, M.D. [2]
Overview
There are no specific liver biopsy findings diagnostic of drug induced injury, but there are several broad histological patterns that reflect the type of injury caused by the inciting drug. Moreover, the same medication can induce a different pattern of liver injury depending on the patient.
Liver Biopsy
The most common histological patterns seen in the drug induced liver injury network are as follows:
- Acute hepatitis (21%)
- Chronic hepatitis (14%)
- Cholestatic hepatitis (29%)
- Acute cholestasis (9%)
- Chronic cholestasis (10%)
On biopsy, drug induced liver injury is characterized by hepatocellular injury and severe inflammation, necrosis, hemorrhage, and rosette formation. Patients with cholestatic injury tend to have more bile plugs and duct paucity. Certain findings on biopsy are predictive of severe and even fatal hepatic injury, including higher degrees of necrosis, microvesicular steatosis, [[fibrosis], and duct reactions. In contrast, eosinophils and granulomas are associated with milder injury.[1]
References
- ↑ Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB; et al. (2014). "Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations". Hepatology. 59 (2): 661–70. doi:10.1002/hep.26709. PMC 3946736. PMID 24037963.